Furthermore, we investigated for the first time the influence of SFTPD haplotypes on susceptibility of PA infection in CF patients.To our best knowledge this is the first study to describe and analyze SFTPD as a genetic modifier in onset of chronic PA infection in CF patients. This evidence concerns the gene SFTPD and cystic fibrosis.